soars

A look at the day ahead in U.S. and global markets from Mike Dolan Retaining a persistent, if uncertain, threat of new tariffs, U.S. President Donald Trump quickly switched his attention to technology and artificial intelligence this week – exciting the red-hot sector that’s about to report its latest earnings…

Investing.com– U.S. stock index futures edged higher Wednesday, boosted by Netflix’s strong results and as investors assessed President Donald Trump’s trade policies. At 05:20 ET (10:20 GMT), gained 50 points, or 0.1%, climbed 24 points, or 0.4%, and rose 165 points, or 0.8%. The main Wall Street indices posted strong…

Investing.com — Shares of GSI Technology (NASDAQ:) surged 59% following the announcement that the company has been selected for a potential contract award by the U.S. Army under the Department of Defense Small Business Innovation Research (SBIR) program. The contract, which could be worth up to $250,000, is aimed at…

Investing.com — Aadi Bioscience, Inc. (NASDAQ:AADI) shares surged 24% in pre-open trading Friday following the company’s announcement of a strategic licensing agreement and a significant asset sale. The biopharmaceutical company revealed it has entered into an exclusive license for a portfolio of antibody-drug conjugates (ADCs) and agreed to sell its…

Investing.com — Shares of Prothena Corporation plc (NASDAQ:PRTA) surged 43% today, marking the most significant intraday rise since September 2022, even though the company announced that its Phase IIb PADOVA study, conducted by partner Roche, did not meet its primary endpoint in a trial for an experimental Parkinson’s disease drug.…

Investing.com — Shares of Nukkleus, Inc. (NASDAQ: NUKK) skyrocketed today, following the company’s announcement of a strategic acquisition that marks its entry into the defense sector. The fintech company, which has historically focused on the cryptocurrency market, revealed it has acquired a 51% controlling stake in Star 26 Capital Inc.,…

Investing.com — Shares of Teva Pharmaceutical Industries Ltd. (NYSE:) surged 17% following the announcement of successful Phase 2b study results for its investigational drug duvakitug, which is being developed to treat inflammatory bowel disease (IBD). The study, conducted in collaboration with Sanofi (NASDAQ:), met its primary endpoints in patients with…

Investing.com– U.S. stock index futures edged higher Friday, bouncing after a losing session on Wall Street as investors digest strong numbers from chipmaker Broadcom (NASDAQ:) and look forward to a Federal Reserve meeting next week.  At 05:50 ET (10:50 GMT), rose 125 points, or 0.3%, gained 22 points, or 0.4%,…